Mia's Feed
Medical News & Research

Understanding the Rise in Measles Cases and How to Prevent Them

Understanding the Rise in Measles Cases and How to Prevent Them

Share this article

The U.S. faces its largest measles outbreak in over 30 years due to declining vaccination rates. Experts highlight airborne transmission and stress the importance of community vaccination to stop the spread.

2 min read

The United States is currently experiencing its most significant measles outbreak in over three decades, with at least 1,277 confirmed cases spread across 36 states and the District of Columbia. Experts from Virginia Tech highlight the primary causes behind this resurgence and emphasize practical steps to curb the spread.

According to Linsey Marr, an environmental engineer specializing in aerosol virus transmission, the resurgence is mainly due to declining vaccination rates. Despite being considered eliminated in 2000, measles has reemerged as vaccination coverage drops. Marr explains that measles spreads similarly to COVID-19 through tiny respiratory particles capable of lingering in the air for hours, even after an infected individual has left the vicinity. These particles can be inhaled by others, leading to new infections. Historical cases from the 1980s underline this airborne transmission, where unvaccinated children contracted the virus after brief exposure in medical clinics.

The transmission of measles is predominantly driven by human behavior, such as gatherings and travel, rather than weather conditions. Lisa M. Lee, an infectious disease epidemiologist, underscores the extreme contagiousness of measles—one unvaccinated person can infect up to 20 others, surpassing the spread rate of COVID-19.

Preventing this outbreak is entirely possible through vaccination. Achieving at least 95% vaccination coverage in communities is crucial to protect the most vulnerable, particularly children. The predominant vaccine regimen includes two doses—first at 12 months of age and second between 4 and 6 years old. Adults who have not been vaccinated or previously contracted measles can still be immunized. The combined efficacy of two vaccine doses is approximately 97%, with even a single dose offering around 93% protection.

As measles cases rise, health experts advise reconsidering vaccination, emphasizing the vaccine's safety and importance. Side effects are typically mild and temporary, including slight discomfort at the injection site or mild fever, which are far less severe than complications from the disease itself. Measles can cause serious health problems, such as ear infections leading to hearing loss, vision impairment, brain inflammation, and in severe cases, death—especially in young children.

The key to stopping the spread is community-wide vaccination efforts. Achieving high immunization rates can prevent future outbreaks and protect public health. Individuals are encouraged to consult healthcare providers for accurate information and to get vaccinated promptly.

Source: https://medicalxpress.com/news/2025-07-experts-measles-surge.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Electrical Stimulation Enables Paralyzed Rats to Regain Movement After Spinal Injury

A groundbreaking bioelectric implant developed by international researchers shows promise in restoring movement in rats with spinal cord injuries, opening new avenues for human treatments through targeted electrical stimulation.

Artificial Intelligence Gap Impeding Healthcare Advancements in the Global South

A new study highlights the global disparities in AI adoption in healthcare, emphasizing the challenges faced by the Global South and the need for equitable international collaboration to foster health equity.

Genetics and Treatment Type Key Factors in Second Cancer Risks Among Childhood Cancer Survivors

New research shows that genetics and therapy type significantly influence the risk of second cancers in childhood cancer survivors, paving the way for personalized follow-up care.